Indivior PLC (STU:2IVB)
€ 11.1 0.3 (2.78%) Market Cap: 1.41 Bil Enterprise Value: 1.37 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 61/100

Indivior PLC at Bank of America Global Healthcare Conference Transcript

May 11, 2023 / 12:00AM GMT
Release Date Price: €17.48 (-0.57%)
Dominique Schorn

I'm Dominique Schorn, European Healthcare spec sales of Bank of America. On the line today, going to be asking Q&A is Graham Parry, Co-Head of our European pharma research team. And if you have any questions, of course, raise your hand and I'll go ahead and call on you. And today, we're hosting Indivior. Mark Crossley, the CEO, thank you for coming today.

Mark Crossley
Indivior PLC - CEO & Executive Director

Thank you.

Dominique Schorn

And I think we're just going to start off with a presentation, and then we'll go into the Q&A.

Mark Crossley
Indivior PLC - CEO & Executive Director

Yes, I think just a quick intro to the business. And Graham, just because you're remote, and I can't see you doesn't mean you can be mean today. Appropriate questions only, please. So I think we'll take the forward-looking statements. I'll take those as read. I think we're all familiar with those. And as said, I'm Mark Crossley, the CEO of Indivior.

And I think

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot